This is a preview of subscription content,to check access.
Access this article
JackJr CRB, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement 2018, 14: 535–562.
Brandon JA, Farmer BC, Williams HC, Johnson LA. APOE and alzheimer’s disease: Neuroimaging of metabolic and cerebrovascular dysfunction. Front Aging Neurosci 2018, 10: 180.
Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y. Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci 2022, 25: 1020–1033.
Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies. Nat Rev Neurol 2019, 15: 501–518.
Carbonell F, Zijdenbos AP, McLaren DG, Iturria-Medina Y, Bedell BJ, Alzheimer’s Disease Neuroimaging Initiative. Modulation of glucose metabolism and metabolic connectivity by β-amyloid. J Cereb Blood Flow Metab 2016, 36: 2058–2071.
Miners JS, Schulz I, Love S. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer’s disease. J Cereb Blood Flow Metab 2018, 38: 103–115.
Bulgart HR, Neczypor EW, Wold LE, Mackos AR. Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener 2020, 15: 42.
Pluvinage JV, Wyss-Coray T. Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration. Nat Rev Neurosci 2020, 21: 93–102.
Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Paricio M, et al. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer’s disease: Primary results of the AMBAR Study. Alzheimers Dement 2020, 16: 1412–1425.
Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 2020, 581: 71–76.
Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol 2018, 18: 759–772.
Hussain B, Fang C, Chang J. Blood-brain barrier breakdown: An emerging biomarker of cognitive impairment in normal aging and dementia. Front Neurosci 2021, 15: 688090.
This research highlight was supported by the Science and Technology Innovation 2030 Major Projects (2022ZD0211600), the National Natural Science Foundation of China (82271574, 82071204, and 81871069), the Key Projects of Commission of Health, Jiangsu Province (ZDB2020008).
Conflict of interest
All authors declare no competing interest.
About this article
Cite this article
Sun, R., Xie, C. Peripheral ApoE4 Leads to Cerebrovascular Dysfunction and Aβ Deposition in Alzheimer's Disease. Neurosci. Bull. 39, 1330–1332 (2023). https://doi.org/10.1007/s12264-023-01058-1